Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

Sponsor
Timothy Chuter, MD (Other)
Overall Status
Recruiting
CT.gov ID
NCT00483249
Collaborator
(none)
250
2
1
259
125
0.5

Study Details

Study Description

Brief Summary

This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

Condition or Disease Intervention/Treatment Phase
  • Device: Endovascular Branched Stent-Graft
N/A

Detailed Description

A TAAA or PVAAA is an abnormal enlargement of the aorta, the main artery in the chest and abdomen. The standard operation for TAAA of PVAAA is performed through a long incision extending down the side of the chest and the front of the abdomen. In the standard operation, the weak area of the aorta is replaced with a fabric sleeve (graft). The investigational operation is done making small incisions in both groins and the right arm and placing a graft in the aorta through tubes that are inserted through the femoral and brachial arteries, than fastening it in position with metal springs(stents). The combination of a stent and a graft is known as a stent-graft. Compared with standard operation, the potential advantages of endovascular TAAA/PVAAA repair include less pain, less disturbance of intestinal function, a lower risk of pulmonary or cardiac complications and shorter hospital stay. The main disadvantage of endovascular TAAA/PVAAA is an unknown success rate.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
Study Start Date :
May 1, 2005
Anticipated Primary Completion Date :
Dec 1, 2026
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interventional

Endovascular Branched Stent-Graft: The investigational operation is done making small incisions in both groins and the right arm and placing a graft in the aorta through tubes that are inserted through the femoral and brachial arteries, than fastening it in position with metal springs(stents).

Device: Endovascular Branched Stent-Graft
Industry manufactured branched stent-graft for treatment of TAAA/PVAAA.

Outcome Measures

Primary Outcome Measures

  1. Successful implantation of TAAA branched stent-graft. [1 month]

Secondary Outcome Measures

  1. Long term success of TAAA branched stent-graft treatment. [5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  1. Aortic aneurysms:
  • greater than or equal to 6 cm in diameter in men,

  • greater than or equal to 5.5 cm in diameter in women,

  • and/or larger than 5 cm in diameter and enlarging at a rate of more than 5 mm/year,

  • and/or iliac aneurysms larger than 4 cm in diameter.

  1. Anticipated mortality comparable to published rates with conventional surgical treatment.

  2. Life expectancy more than 2 years.

  3. Ability to give informed consent.

  4. Willingness to comply with follow-up schedule.

  5. Suitable arterial anatomy for endovascular repair.

Exclusion Criteria

  1. Free rupture of the aneurysm.

  2. Pregnancy.

  3. Known allergy to Nitinol, stainless steel, or polyester.

  4. Unwillingness or inability to comply with the follow up schedule.

  5. Serious systemic or groin infection.

  6. Uncorrectable coagulopathy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Division of Vascular Surgery, SFVAMC San Francisco California United States 94121
2 Division of Vascular Surgery, UCSF San Francisco California United States 94143

Sponsors and Collaborators

  • Timothy Chuter, MD

Investigators

  • Principal Investigator: Warren J Gasper, MD, University of California, San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Timothy Chuter, MD, Professor Emeritus of Surgery, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00483249
Other Study ID Numbers:
  • 10-02810
First Posted:
Jun 6, 2007
Last Update Posted:
Jul 8, 2022
Last Verified:
Jul 1, 2022
Keywords provided by Timothy Chuter, MD, Professor Emeritus of Surgery, University of California, San Francisco
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 8, 2022